Non-invasive prenatal testing (NIPT) is performed worldwide to detect common
chromosomal aneuploidies. The analysis of cell-free DNA (cfDNA) in maternal blood for …

Eight years have passed since noninvasive prenatal testing (NIPT) was clinically evaluated
and data on NIPT for trisomy 21, 18 and 13 were collected. The data revealed that NIPT is …

Purpose We systematically reviewed the published literature on test failure rates for the
sequencing of cell-free DNA (cfDNA) in maternal plasma to identify Down syndrome …

Objective To evaluate the reasons for nonreportable cell‐free DNA (cfDNA) results in
noninvasive prenatal testing (NIPT), we retrospectively studied maternal characteristics and …

Objective Maternal characteristics and neonatal outcomes associated with cell-free DNA
(cfDNA) results were analysed retrospectively to assess the details of false-positive and …

To support people with Down syndrome (DS), it is essential to know and predict the number
of live births of children with this condition. In this study, we estimated DS live birth rates on …

Courtesy stigma, which arises from close connections to people with stigmatized
characteristics, negatively affects interpersonal relations. This study aimed to evaluate …

Objective The purpose of this study is to compare the fetal fractions during non-invasive
prenatal testing (NIPT) in singleton pregnancies according to gestational age and maternal …

Objective To evaluate the “nonreportable” rate in patients treated with heparin and to
determine the effect of heparin on the results of noninvasive prenatal testing (NIPT). Method …

Down syndrome is the most frequent chromosomal abnormality among live-born infants. All
Down syndrome patients have mental retardation and are prone to develop early onset …